ULTRAVIST 150 Drug Patent Profile
✉ Email this page to a colleague
When do Ultravist 150 patents expire, and what generic alternatives are available?
Ultravist 150 is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in ULTRAVIST 150 is iopromide. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopromide profile page.
Summary for ULTRAVIST 150
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Clinical Trials: | 11 |
Patent Applications: | 2,426 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ULTRAVIST 150 at DailyMed |
Recent Clinical Trials for ULTRAVIST 150
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GE Healthcare | Phase 4 |
Bayer | Phase 4 |
Guerbet/Liebel-Flarsheim | Phase 4 |
Pharmacology for ULTRAVIST 150
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ULTRAVIST 150
US Patents and Regulatory Information for ULTRAVIST 150
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | ULTRAVIST 150 | iopromide | INJECTABLE;INJECTION | 020220-004 | May 10, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ULTRAVIST 150
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | ULTRAVIST 150 | iopromide | INJECTABLE;INJECTION | 020220-004 | May 10, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ULTRAVIST 150
See the table below for patents covering ULTRAVIST 150 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0015867 | DIAMIDES OF TRIIODO-ISOPHTHALIC ACIDS, THEIR PREPARATION AND X-RAY CONTRAST AGENTS CONTAINING THEM | ⤷ Try a Trial |
Ireland | 49647 | NON-IONIC X-RAY CONTRAST AGENTS | ⤷ Try a Trial |
Ireland | 800467 | ⤷ Try a Trial | |
Japan | S55153755 | TRIIODOISOPHTHALIC ACID DIAMIDE DERIVATIVE* ITS MANUFACTURE AND X RAY CONTRAST AGENT CONTAINING IT | ⤷ Try a Trial |
Israel | 59542 | ISOPHTHALIC ACID DIAMIDE DERIVATIVES,NON-IONIC X-RAY CONTRAST PREPARATIONS CONTAINING THE SAME AND PROCESS FOR THE PREPARATION THEREOF | ⤷ Try a Trial |
Greece | 66668 | ⤷ Try a Trial | |
Spain | 491254 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |